Advisor Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$50K Sell
9,234
-733
-7% -$4.13K ﹤0.01% 3416
2019
Q3
$58K Buy
9,967
+3,425
+52% +$23.3K ﹤0.01% 3276
2019
Q2
$50K Buy
6,542
+324
+5% +$1.74K ﹤0.01% 3364
2019
Q1
$32K Buy
6,218
+1,400
+29% +$9.71K ﹤0.01% 3690
2018
Q4
$32K Sell
4,818
-11
-0.2% -$123 ﹤0.01% 3497
2018
Q3
$83K Buy
4,829
+75
+2% +$1.11K ﹤0.01% 2890
2018
Q2
$66K Sell
4,754
-1,656
-26% -$28K ﹤0.01% 2868
2018
Q1
$99K Buy
6,410
+767
+14% +$11K ﹤0.01% 2565
2017
Q4
$65K Sell
5,643
-2,500
-31% -$37.2K ﹤0.01% 2904
2017
Q3
$155K Sell
8,143
-654
-7% -$13.5K ﹤0.01% 2046
2017
Q2
$212K Buy
8,797
+3,351
+62% +$73.5K ﹤0.01% 1744
2017
Q1
$108K Sell
5,446
-923
-14% -$20.6K ﹤0.01% 2104
2016
Q4
$153K Sell
6,369
-2,829
-31% -$78.8K ﹤0.01% 1760
2016
Q3
$256K Buy
9,198
+4,077
+80% +$108K 0.01% 1364
2016
Q2
$123K Buy
+5,121
New +$145K ﹤0.01% 1774

Other funds holding PGEN

Advisor Group's PGEN Position: Q4 2019 in Review

Advisor Group reduced its Precigen (PGEN) stake by 7.4% in Q4 2019, selling an estimated $4.13K and leaving 9,234 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #3416.

Advisor Group first reported a position in PGEN in Q2 2016 and has held it in 15 quarters since. The position peaked at $256K in Q3 2016. 167 funds tracked by Wall St. Rank hold PGEN as of Q4 2019.

  • Advisor Group held 9,234 shares of Precigen worth $50K as of Q4 2019.
  • Advisor Group sold 733 Precigen shares in Q4 2019, an estimated $4.13K.
  • Precigen made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3416 holding.
  • Advisor Group first reported a position in Precigen in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Precigen position peaked at $256K in Q3 2016.
  • 167 funds tracked by Wall St. Rank held Precigen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.